Skip to content
Recall Observatory FDA recall evidence

Drug product

Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01

D-0358-2022

December 29, 2021

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 89324
Status
Terminated
Classification
Class III
Quantity
23,965 100 count bottles
Official record key
drug-enforcement:D-0358-2022

Official wording

Reason: Out-of-specification impurity test result observed at 18-month long term stability time point.

Code information: Lot # S000268, Exp. date January 2022

Distribution pattern: Product Distributed in NY and OH.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification